---
title: Jira Validation for GxP: A Practical CSV Guide
date: 2026-10-29
description: How to validate Jira as a GxP computerized system: intended use, risk-based scope, CSV file imports, change control and the evidence inspectors expect.
author: Qualitum
cover: https://media.babylovegrowth.ai/blog-images/organization-48457/1793157327562_Quality-specialist-tests-Jira-approval-workflow-in-laboratory.jpeg
coverAlt: Quality specialist tests Jira approval workflow in laboratory
---

Jira needs computer system validation (CSV) when your quality system or GxP records depend on it. Typical examples are change requests, deviations, CAPA actions, test execution records and approvals. Validation is not about certifying Jira itself. It is about showing, with documented evidence, that your configured instance does what you intend it to do, and keeps doing it after every change. The effort should scale with risk, not with the size of the tool.

This guide walks through how to scope that work, what to test, how to treat CSV file imports and exports (the other meaning of "CSV" that Jira users search for), and which records to keep for an inspection.

## TL;DR

- Jira is in scope for validation when it automates or holds part of your quality system. The regulated company, not Atlassian, is responsible for showing it is fit for its intended use.
- Define the intended use first. Then validate the specific workflows, fields, permissions and integrations that carry GxP risk, not every feature.
- Treat CSV file imports and exports as data migration: prove that values and meaning are not altered.
- Keep a lean evidence set: requirements, risk assessment, protocol, test results, summary and a change log that proves the validated state is maintained.
- A risk-based approach reduces documentation without weakening compliance, provided the rationale is written down.

## Table of Contents

- [When Jira falls under validation](#when-jira-falls-under-validation)
- [Which rules apply in the US and EU](#which-rules-apply-in-the-us-and-eu)
- [Define intended use and system boundary](#define-intended-use-and-system-boundary)
- [Scope the validation by risk](#scope-the-validation-by-risk)
- [What to test in a configured Jira instance](#what-to-test-in-a-configured-jira-instance)
- [CSV files in Jira: validating imports and exports](#csv-files-in-jira-validating-imports-and-exports)
- [The evidence inspectors expect](#the-evidence-inspectors-expect)
- [Keeping Jira in a validated state](#keeping-jira-in-a-validated-state)
- [Doing less paperwork without weakening compliance](#doing-less-paperwork-without-weakening-compliance)
- [Our perspective: validate the decisions, not the tool](#our-perspective-validate-the-decisions-not-the-tool)
- [Where Qualitum fits](#where-qualitum-fits)
- [FAQ](#faq)
- [Sources](#sources)

## When Jira falls under validation

Jira starts life as a project tracker. It becomes a GxP system the moment a regulated decision or record lives in it. If a change control ticket approves a process change, if test cases and results for another validated system are executed in it, or if a deviation is closed with an electronic approval, an inspector will treat it as part of your quality system.

In the US, the FDA's position is clear for device manufacturers: software used to automate production or any part of the quality system must be validated for its intended use under [21 CFR §820.70(i)](https://www.fda.gov/media/73141/download), a requirement that took effect on June 1, 1997. The same guidance notes that an off-the-shelf software vendor may not carry direct regulatory responsibility, but the regulated manufacturer must make sure the system is validated for its own specific use.

That last point settles a common argument. Atlassian's own quality processes can inform your supplier assessment. They do not replace your validation. The EMA takes the same line for clinical trials: [sponsors remain ultimately responsible](https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/notice-sponsors-validation-qualification-computerised-systems-used-clinical-trials_en.pdf) for validation and for adequate documented evidence, even when they rely on vendor qualification documentation.

A useful test: if the Jira record would be shown to an inspector as evidence that a quality activity happened, the system producing it needs a validation rationale. If Jira only tracks the IT team's sprint backlog, document that decision in your system inventory and move on.

![When Jira falls under validation — overview diagram](https://media.babylovegrowth.ai/blog-images/organization-48457/1793157409766_When-Jira-falls-under-validation-overview-diagram.jpeg)

## Which rules apply in the US and EU

The two reference points most Jira validation plans cite are the FDA's software validation expectations and EU GMP Annex 11.

**United States.** The FDA's [General Principles of Software Validation](https://www.fda.gov/media/73141/download) says validation should run through the entire software life cycle, combining life cycle management with risk management based on intended use and the safety risks involved. More recently, the FDA's [Computer Software Assurance for Production and Quality Management System Software](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/computer-software-assurance-production-and-quality-management-system-software) guidance, issued in 2026, gives recommendations for a risk-based approach to establishing confidence in automation used for production or quality systems. For a tool like Jira, this supports putting scripted testing effort where failure would matter and relying on lighter assurance elsewhere. If you are unsure how the two models differ in practice, our comparison of [CSA vs CSV for validation teams](https://blog.qualitum.ai/csa-vs-csv) covers it.

**European Union.** [EudraLex Volume 4, Annex 11](https://health.ec.europa.eu/document/download/8d305550-dd22-4dad-8463-2ddb4a1345f1_en?filename=annex11_01-2011_en.pdf) requires that computerized systems used in GMP activities be validated, with risk management applied throughout the lifecycle. It also expects an up-to-date inventory of relevant systems and their GMP functionality, and a detailed system description for critical ones.

**Other markets.** Many other regulators reference Annex 11 or PIC/S equivalents. If you operate across jurisdictions, write the validation package to the stricter expectation and note where a market adds something specific. Do not present one country's rule as universal in your own documents.

![Which rules apply in the US and EU — overview diagram](https://media.babylovegrowth.ai/blog-images/organization-48457/1793157371472_Which-rules-apply-in-the-US-and-EU-overview-diagram.jpeg)

## Define intended use and system boundary

Most weak Jira validations fail at this step, because "Jira" is not a system. Your configured instance is: projects, issue types, workflows, custom fields, permission schemes, automation rules, marketplace apps and integrations.

Write an intended use statement that answers four questions:

1. Which GxP processes use Jira (change control, deviation management, test execution, requirements tracing)?
2. Which records does it create or hold, and which are the official record versus a convenience copy?
3. Who uses it, and what can each role do?
4. What does it connect to (a QMS, a source code repository, a document management system, a CI pipeline)?

Then draw the boundary. Cloud or data center, which projects are in scope, which apps are in scope. A Jira instance with a GxP change control project and forty unrelated engineering projects can be validated by scoping the GxP projects and controlling the instance-level settings that affect them, such as global permissions and shared workflows.

Decide early whether Jira is the system of record or a workflow tool feeding another system. If final approved documents live in your QMS and Jira only routes tasks, the risk and the validation scope shrink considerably. If you want a requirements-first approach, our [requirements drafting](https://qualitum.ai/use-cases/drafting) workflow shows how a sourced first-draft user requirements specification is built.

## Scope the validation by risk

Annex 11 states that decisions on the extent of validation and data integrity controls [must rest on a justified and documented risk assessment](https://health.ec.europa.eu/document/download/8d305550-dd22-4dad-8463-2ddb4a1345f1_en?filename=annex11_01-2011_en.pdf). ICH Q9 adds that the level of effort, formality and documentation of quality risk management should be [commensurate with the level of risk](https://database.ich.org/sites/default/files/Q9%20Guideline.pdf).

In practice, that means ranking Jira functions rather than testing everything equally. A simple model:

| Jira function | Typical GxP impact | Suggested assurance approach |
|---|---|---|
| Electronic approval of a change or deviation | High: it is the evidence of authorization | Scripted tests with expected results and objective evidence |
| Workflow transitions that enforce review order | High to medium | Scripted tests of each path, including blocked paths |
| Permission scheme and role separation | High: protects integrity of approvals | Scripted tests per role, plus periodic access review |
| Audit history and field change tracking | High: supports data integrity | Verify capture of who, what, when, and prior value |
| Custom fields that feed reports | Medium | Unscripted or limited testing with recorded results |
| Dashboards and filters for convenience | Low | Vendor assurance and a documented rationale |
| Standard, unmodified Jira features | Low | Supplier assessment and use in the intended configuration |

The point of the table is the last column. Each row has a written rationale, and low-risk items get less testing because you can explain why. Our guide to [CSV risk assessment](https://blog.qualitum.ai/csv-risk-assessment) goes deeper on how to document that reasoning so it holds up under questioning.

## What to test in a configured Jira instance

A workable validation plan for Jira usually covers these areas.

### Workflows and conditions

Jira workflows can include conditions and validators on transitions, which stop an issue moving forward unless requirements are met. Atlassian documents these in its conditions and validators material. If your process relies on them, for example to prevent closing a deviation without an approval, test both the allowed path and the blocked path. Negative tests are what show the control works.

### Permissions and electronic signatures

Test every role against every GxP action. Can the author approve their own change? Can a user edit a closed record? If your approvals depend on an app that adds electronic signature behavior, include that app in scope and in supplier assessment. Identity and access setup, such as single sign-on, belongs in the plan.

### Audit trail and data integrity

Inspectors will ask whether you can reconstruct who changed what and when. Confirm that field changes, status changes and comments are captured, and that users cannot delete or alter history. Apply ALCOA+ thinking: attributable, legible, contemporaneous, original, accurate, plus complete, consistent, enduring and available.

### Integrations and automation rules

Every integration that moves GxP data is its own risk. Test that data crosses the interface intact, that failures are visible, and that an automation rule cannot silently change a record under an approved state. Where Jira connects to a QMS, see how [QMS integration reduces authoring effort](https://blog.qualitum.ai/qms-validation-integration) without breaking traceability.

### Backup, restore and availability

For cloud-hosted instances, your supplier assessment should cover what the vendor provides on backup and continuity. For self-hosted instances, test a restore. Records must stay available and readable for the full retention period.

## CSV files in Jira: validating imports and exports

Many people searching "Jira validation CSV" mean something narrower: a CSV file import failing or an export being inconsistent. That is a practical Jira topic, and in a GxP context it is also a validation topic, because a CSV file is a data transfer between formats.

Annex 11 addresses this directly: when data is transferred to another format or system, validation should include checks that [values and/or meaning are not altered](https://health.ec.europa.eu/document/download/8d305550-dd22-4dad-8463-2ddb4a1345f1_en?filename=annex11_01-2011_en.pdf) during migration. Apply that to Jira like this:

- **Decide whether bulk import into GxP projects is permitted at all.** Many regulated teams restrict it to a controlled migration procedure rather than routine use.
- **Define a mapping specification.** Document which CSV column maps to which Jira field, including date formats, user identifiers, multi-value fields and checkbox or select list values. Mismatched option values are a frequent cause of imports that complete but populate fields incorrectly.
- **Run a test import in a non-production instance** with representative data, including edge cases: blank cells, commas and line breaks inside text, special characters, long descriptions and users that do not exist.
- **Reconcile before and after.** Compare record counts and a risk-based sample of field values between source and target. Record the results as objective evidence.
- **Check what the import does not carry.** History, original timestamps and approvals may not transfer as they were. If the source is the original record, retain it.
- **Control exports the same way.** A CSV export used for a report, a periodic review or a regulatory response should come from a defined filter, with the query and date recorded. Spreadsheet edits after export break the chain to the original record.

If your team uses scheduled exports to email results, treat the schedule and recipient list as configuration under change control. Where Jira is a source for evidence, a controlled export procedure is far easier to defend than ad hoc downloads.

## The evidence inspectors expect

The FDA's software validation guidance describes documentation that includes [defined user requirements, the validation protocol, acceptance criteria, test cases and results, and a validation summary](https://www.fda.gov/media/73141/download) that objectively confirms the software is validated for its intended use. For Jira, a lean package looks like this:

1. **System inventory entry** with GxP functionality noted, as Annex 11 expects.
2. **Intended use statement and user requirements** tied to specific Jira configuration.
3. **Supplier assessment** covering the vendor and any marketplace apps.
4. **Risk assessment** with the rationale for the testing approach per function.
5. **Validation plan and protocol** with acceptance criteria.
6. **Executed test records** with screenshots or system output, tester identity, date and result, plus any deviations and their resolution.
7. **Traceability** from requirement to risk to test.
8. **Validation summary report** stating that the system is fit for intended use and listing open items.
9. **Operating procedures** for administration, access management, change control and periodic review.

Good documentation habits matter beyond Jira. For general guidance on keeping test evidence and records consistent, see these [laboratory documentation standards](https://aresresearchlab.com/research/laboratory-compound-documentation-standards-2026-guide). To see what audit-ready output can look like when automated, read our piece on [audit-ready automated validation documents](https://blog.qualitum.ai/automated-validation-documents).

## Keeping Jira in a validated state

Validation is a point in time. Jira changes constantly, because admins edit workflows, apps update and new fields appear. Annex 11 requires that changes to a computerized system, [including configuration changes](https://health.ec.europa.eu/document/download/8d305550-dd22-4dad-8463-2ddb4a1345f1_en?filename=annex11_01-2011_en.pdf), be made in a controlled manner following a defined procedure.

For Jira, that translates to a handful of habits:

- **Classify changes by impact.** A new dashboard is not a workflow change to the deviation process. Write the classification rules so admins do not decide case by case.
- **Use a sandbox.** Build and test changes outside production, then promote them through the change control process.
- **Review vendor releases.** For cloud, updates arrive on the vendor's schedule. Define how you review release notes, assess impact on GxP functions and run regression checks on high-risk functions.
- **Control app updates** the same way as core changes.
- **Run periodic reviews** of access rights, configuration drift, open incidents and the audit trail. Remove access promptly when roles change.
- **Update the inventory and the validation summary** when the intended use changes.

The full path from planning to retirement is laid out in our [seven-phase CSV lifecycle](https://blog.qualitum.ai/csv-lifecycle), and our [CSV best practices](https://blog.qualitum.ai/csv-best-practices) article covers the habits that keep packages inspection-ready.

## Doing less paperwork without weakening compliance

Teams often validate Jira as heavily as a manufacturing execution system because that is what the template says. A risk-based approach corrects that. ICH Q9 supports proportionate effort, and the FDA's 2026 CSA guidance supports establishing confidence through risk-based assurance rather than uniform scripting.

What saves time in practice:

- Leveraging documented supplier information for standard functions, while still verifying your own configuration.
- Using unscripted or exploratory testing, with recorded results, for low-risk functions.
- Reusing a validated configuration pattern across projects rather than re-validating each project from scratch.
- Capturing evidence at the time of execution, so no one reconstructs it weeks later.

What does not save time: skipping the rationale. A thin package with clear reasoning survives an inspection. A thick package with no reasoning does not.

## Our perspective: validate the decisions, not the tool

We see the same pattern in many life sciences teams. Jira gets validated once, with a heavy protocol, and then drifts. Six months later the workflow has been edited three times, and nobody can show which version was tested. The documentation burden is a quiet tax, and the audit fire drill follows.

Our view is that the unit of validation should be the decision the system supports. Start from the requirement ("no deviation closes without independent QA approval"), tie it to a risk, test it, and keep the link live as the configuration changes. That is why we built Qualitum around agent-authored validation documents, a live traceability matrix, and ALCOA+ checks on every record at write-time and review-time. Human signatures remain authoritative; the agents do the drafting and checking so your engineers can spend their time on judgment.

We deploy privately inside the customer's infrastructure, so validation evidence does not leave your environment. Whether the system under validation is Jira, a LIMS or a CMMS, the principle holds: scope by risk, record the reasoning, and keep the evidence connected. You can see the same approach applied to [LIMS validation](https://blog.qualitum.ai/lims-validation-pharma) and [CMMS validation](https://blog.qualitum.ai/cmms-validation).

> *— Matt*

## Where Qualitum fits

If your Jira validation is stuck at the authoring stage (requirements, risk assessment, IQ/OQ/PQ-style protocols, test evidence review), the [Validate·AI and Operate·AI platform](https://qualitum.ai/platform/) is built for it. Agents draft documents in your templates, check each record against ALCOA+ expectations, and keep traceability current when configuration changes. Our [evidence review workflow](https://qualitum.ai/use-cases/evidence-review) checks executed tests before QA sees them.

![Qualitum](https://csuxjmfbwmkxiegfpljm.supabase.co/storage/v1/object/public/blog-images/organization-48457/1785522367413_qualitum.jpg)

Most teams begin with a paid pilot on one system, then expand. To scope a pilot around your Jira instance, start from the [Qualitum site](https://qualitum.ai/).

## FAQ

### Do we have to validate Jira if we only use it for IT tasks?

No, if no GxP record or quality decision depends on it. Document that conclusion in your system inventory with the reasoning. The moment Jira holds approvals, test evidence or quality records, the intended use changes and validation scope must follow.

### Can we rely on Atlassian's documentation instead of validating?

Not entirely. The FDA states that the regulated manufacturer must make sure the system is validated for its specific intended use, and the EMA says the same about sponsors in clinical trials. Vendor information supports your supplier assessment, but your configuration, workflows and permissions still need testing.

### Do CSV file imports into Jira need validation?

If the import creates or changes GxP records, yes. Treat it as a data migration: map fields, test with representative data, and reconcile source against target to show values and meaning were not altered, as Annex 11 expects.

### How often should we re-validate Jira?

There is no fixed interval in the sources cited here. Maintain the validated state through change control on every configuration or app change, and run periodic reviews on a schedule you define in your procedure, based on risk.

### Is CSA replacing CSV for Jira?

CSA is a risk-based way of doing assurance, not an exemption. You still need intended use, risk assessment and objective evidence. The difference is that low-risk functions need less scripted testing and less paper.

## Sources

- [FDA, General Principles of Software Validation](https://www.fda.gov/media/73141/download)
- [FDA, Computer Software Assurance for Production and Quality Management System Software](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/computer-software-assurance-production-and-quality-management-system-software)
- [European Commission, EudraLex Volume 4, Annex 11](https://health.ec.europa.eu/document/download/8d305550-dd22-4dad-8463-2ddb4a1345f1_en?filename=annex11_01-2011_en.pdf)
- [EMA, Notice to sponsors on validation and qualification of computerised systems used in clinical trials](https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/notice-sponsors-validation-qualification-computerised-systems-used-clinical-trials_en.pdf)
- [ICH Q9, Quality Risk Management](https://database.ich.org/sites/default/files/Q9%20Guideline.pdf)
- [Laboratory compound documentation standards](https://aresresearchlab.com/research/laboratory-compound-documentation-standards-2026-guide)

## Recommended

- [CSV Documentation Best Practices for GxP Teams](https://blog.qualitum.ai/csv-documentation-best-practices)
- [Inspection Ready CSV Risk Assessment for QA: FDA CSA and ICH Q9\(R1\)](https://blog.qualitum.ai/csv-risk-assessment)
- [7 Inspection Ready CSV Best Practices for Validation Managers](https://blog.qualitum.ai/csv-best-practices)
- [Seven Phase CSV Lifecycle for QA: CSA Risk and Automation](https://blog.qualitum.ai/csv-lifecycle)

## FAQ
### Do we have to validate Jira if we only use it for IT tasks?
No, if no GxP record or quality decision depends on it. Document that conclusion in your system inventory with the reasoning. The moment Jira holds approvals, test evidence or quality records, the intended use changes and validation scope must follow.

### Can we rely on Atlassian's documentation instead of validating?
Not entirely. The FDA states that the regulated manufacturer must make sure the system is validated for its specific intended use, and the EMA says the same about sponsors in clinical trials. Vendor information supports your supplier assessment, but your configuration, workflows and permissions still need testing.

### Do CSV file imports into Jira need validation?
If the import creates or changes GxP records, yes. Treat it as a data migration: map fields, test with representative data, and reconcile source against target to show values and meaning were not altered, as Annex 11 expects.

### How often should we re-validate Jira?
There is no fixed interval in the sources cited here. Maintain the validated state through change control on every configuration or app change, and run periodic reviews on a schedule you define in your procedure, based on risk.

### Is CSA replacing CSV for Jira?
CSA is a risk-based way of doing assurance, not an exemption. You still need intended use, risk assessment and objective evidence. The difference is that low-risk functions need less scripted testing and less paper.
